Xavier Lescure

3.1k total citations
14 papers, 94 citations indexed

About

Xavier Lescure is a scholar working on Infectious Diseases, Epidemiology and Pharmacology. According to data from OpenAlex, Xavier Lescure has authored 14 papers receiving a total of 94 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 4 papers in Epidemiology and 3 papers in Pharmacology. Recurrent topics in Xavier Lescure's work include SARS-CoV-2 and COVID-19 Research (4 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and COVID-19 Clinical Research Studies (3 papers). Xavier Lescure is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (4 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and COVID-19 Clinical Research Studies (3 papers). Xavier Lescure collaborates with scholars based in France, India and United Kingdom. Xavier Lescure's co-authors include Jean‐Christophe Lucet, Laurent Mandelbrot, Christophe Vayssière, Cyril Huissoud, Philippe Deruelle, I. Nisand, Dominique Luton, Vincent Fihman, A. Therby and Yann Nguyen and has published in prestigious journals such as PLoS ONE, International Journal of Infectious Diseases and European Journal of Clinical Microbiology & Infectious Diseases.

In The Last Decade

Xavier Lescure

14 papers receiving 92 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xavier Lescure France	5	37	31	27	16	15	14	94
Jesse Schnall Australia	3	51 1.4×	5 0.2×	12 0.4×	8 0.5×	12 0.8×	7	114
Valentina Isernia Spain	5	79 2.1×	9 0.3×	30 1.1×	6 0.4×	23 1.5×	10	112
Khozya Zyambo Zambia	6	48 1.3×	8 0.3×	11 0.4×	20 1.3×	17 1.1×	12	106
Leen Ghonem Saudi Arabia	7	64 1.7×	4 0.1×	31 1.1×	5 0.3×	32 2.1×	13	152
E. Díaz Santos Spain	4	23 0.6×	2 0.1×	21 0.8×	10 0.6×	18 1.2×	6	100
Giacomo Guido Italy	6	39 1.1×	3 0.1×	20 0.7×	10 0.6×	20 1.3×	22	105
Alexandria Chung United Kingdom	3	66 1.8×	5 0.2×	36 1.3×	3 0.2×	20 1.3×	6	116
Ana Atti United Kingdom	5	72 1.9×	17 0.5×	7 0.3×	24 1.5×	3 0.2×	12	114
Stephanie E. Griese United States	7	49 1.3×	12 0.4×	6 0.2×	16 1.0×	37 2.5×	12	146
Daniel K. Nomah Spain	6	44 1.2×	20 0.6×	43 1.6×	2 0.1×	6 0.4×	18	96

Countries citing papers authored by Xavier Lescure

Since Specialization

Citations

This map shows the geographic impact of Xavier Lescure's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xavier Lescure with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xavier Lescure more than expected).

Fields of papers citing papers by Xavier Lescure

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xavier Lescure. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xavier Lescure. The network helps show where Xavier Lescure may publish in the future.

Co-authorship network of co-authors of Xavier Lescure

This figure shows the co-authorship network connecting the top 25 collaborators of Xavier Lescure. A scholar is included among the top collaborators of Xavier Lescure based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xavier Lescure. Xavier Lescure is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Hansmann, Yves, Massimo Lodi, Cameron Mura, et al.. (2022). 3D-printed simulator for nasopharyngeal swab collection for COVID-19. Infectious Diseases Now. 52(3). 138–144. 1 indexed citations

Dinh, Aurélien, et al.. (2022). Impact of Omicron surge in community setting in greater Paris area. PubMed Central. 1(2). S20–S20. 1 indexed citations

Bouzid, Donia, Jimmy Mullaert, Quentin Le Hingrat, et al.. (2021). Correction: Characteristics associated with COVID-19 or other respiratory viruses’ infections at a single-center emergency department. PLoS ONE. 16(1). e0246458–e0246458. 3 indexed citations

Deruelle, Philippe, Cyril Huissoud, Xavier Lescure, et al.. (2020). Infection par le SARS-CoV-2 chez les femmes enceintes : état des connaissances et proposition de prise en charge par CNGOF. Gynécologie Obstétrique Fertilité & Sénologie . 48(5). 436–443. 38 indexed citations

Bouzid, Donia, Benoît Visseaux, Anne Perozziello, et al.. (2020). Factors associated with single-room assignment among patients admitted through the emergency department during influenza epidemics. PLoS ONE. 15(8). e0237214–e0237214. 2 indexed citations

Woerther, Paul‐Louis, Camille d’Humières, Xavier Lescure, et al.. (2020). Is the term “anti-anaerobic” still relevant?. International Journal of Infectious Diseases. 102. 178–180. 8 indexed citations

Bouzid, Donia, Jimmy Mullaert, Quentin Le Hingrat, et al.. (2020). Characteristics associated with COVID-19 or other respiratory viruses’ infections at a single-center emergency department. PLoS ONE. 15(12). e0243261–e0243261. 6 indexed citations

Gérard, Stéphane, Gabriel Birgand, C. Rioux, et al.. (2020). Impact of admission to high-risk isolation room on patients’ and healthcare workers’ perceptions: A qualitative cross-assessment Approach. Infectious Diseases Now. 51(3). 247–252. 2 indexed citations

Isernia, Valentina, Zélie Julia, Sylvie Le Gac, et al.. (2020). SARS-COV2 infection in 30 HIV-infected patients followed-up in a French University Hospital. International Journal of Infectious Diseases. 101. 49–51. 14 indexed citations

10.

Dinh, Aurélien, Alexandre Bleibtreu, Laurène Deconinck, et al.. (2020). COVIDOM : une expérience de télémédecine unique pour la gestion du COVID-19. Médecine et Maladies Infectieuses. 50(6). S19–S19. 1 indexed citations

11.

Bru, J.P., S. Alfandari, Alexandre Bleibtreu, et al.. (2019). Carbapenems versus beta-lactam/beta-lactamase inhibitors to treat ESBL-producing Enterobacteriaceae infections. Médecine et Maladies Infectieuses. 50(4). 313–315. 2 indexed citations

12.

Sénard, Olivia, Matthieu Lafaurie, Philippe Lesprit, et al.. (2019). Efficacy of cefoxitin versus carbapenem in febrile male urinary tract infections caused by extended spectrum beta-lactamase–producing Escherichia coli: a multicenter retrospective cohort study with propensity score analysis. European Journal of Clinical Microbiology & Infectious Diseases. 39(1). 121–129. 14 indexed citations

13.

Charani, Esmita, Ingrid Smith, Brita Skodvin, et al.. (2018). The implementation of antimicrobial stewardship in low, middle and high income countries. International Journal of Infectious Diseases. 73. 140–140. 1 indexed citations

14.

Douadi, Y., Xavier Lescure, & J.L. Schmit. (2000). [A new antibiotic: levofloxacine].. PubMed. 29(21). 1184–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact